Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Insomnia Therapeutics Market Grown from 2024 to 2025?#_x000D_

In the past few years, the insomnia therapeutics market has been expanding substantially. Projected growth shows an increase from $3.03 billion in 2024 to $3.21 billion in 2025, maintaining a compound annual growth rate (CAGR) of 6.0%. This notable growth in the preceding period is due to the escalating prevalence of insomnia, heightened awareness of sleep disorders, rising implementation of cognitive behavioral therapy for insomnia (CBT-I), the broadening scope of pharmaceutical interventions, and an increase in over-the-counter sleep aid usage._x000D_

_x000D_

#What Growth Rate Is Anticipated for the Insomnia Therapeutics Market in the Coming Years?#_x000D_

The market size of insomnia therapeutics is projected to experience significant growth in the coming years, reaching $4.01 billion by 2029 at a CAGR of 5.7%. Factors contributing to this increase during the forecasted period include the evolution of AI in sleep monitoring, heightened demand for tailored medicine, a rising elderly populace struggling with sleep disorders, increasing consciousness about mental health, and the development of new, innovative insomnia drugs. Key trends expected during this period encompass the amalgamation of digital therapeutics into insomnia treatment, growing preference for non-drug therapies, a rise in the use of wearable sleep monitoring devices, advancements in newer generations of sleep medicines, and the expansion of telemedicine for managing sleep disorders._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp_x000D_

_x000D_

#Who Are the Leading Companies in the Insomnia Therapeutics Market?#_x000D_

Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., Cerêve Inc._x000D_

_x000D_

#What Are the Key Drivers of the Insomnia Therapeutics Market?#_x000D_

The growth of the insomnia therapeutics market is anticipated to gain momentum due to heightened stress levels and alterations in lifestyles. These factors, signifying a shift in psychological and behavioural practices leading to emotional stress and interrupted sleep cycles, are primarily fueled by relentless connection to the digital world. Such incessant connectivity blurs the line between professional and personal life, leaving little room for genuine mental relaxation. To combat this, insomnia therapeutics provides robust, scientifically proven treatments that aid in reinstating healthy sleep schedules, manage sleep-induced anxiety, and promote mental wellness in light of contemporary stressors. For example, data from the American Psychiatric Association (APA), a psychiatry group in the U.S, revealed that the percentage of American adults experiencing anxiety rose from 32% in 2022, to 37% in 2023 and spiked to 43% in 2024. Accordingly, escalating stress levels and lifestyle transitions are fuelling the expansion of the insomnia therapeutics market._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp_x000D_

_x000D_

#What Are the Key Market Segments in the Insomnia Therapeutics Industry?#_x000D_

The insomnia therapeutics market covered in this report is segmented –_x000D_

_x000D_

1) By Treatment Type: Drugs, Medical Devices_x000D_

2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches_x000D_

3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration_x000D_

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers_x000D_

_x000D_

Subsegments:_x000D_

1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs_x000D_

2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices_x000D_

_x000D_

#What Are the Latest Trends in the Insomnia Therapeutics Market?#_x000D_

Leading firms in the insomnia therapeutics market are concentrating their efforts on the creation of innovative treatments such as dual orexin receptor antagonists (DORAs) in order to provide more specifically targeted remedies with fewer potential side effects and higher safety standards. DORA treatment operates by inhibiting both orexin-1 and orexin-2 receptors in the brain, thereby reducing wakefulness and encouraging sleep, and is frequently utilized for insomnia patients. A case in point is the Switzerland-based Idorsia Pharmaceuticals Ltd., which in June 2023, introduced QUVIVIQ (daridorexant), a groundbreaking DORA solution crafted to combat chronic insomnia disorder. This treatment seeks to diminish nighttime wakefulness whilst preserving the natural structure of sleep, which results in enhanced sleep initiation, continuation, and daytime function for patients. Its sanction symbolizes a notable progression in curing insomnia, presenting a unique method distinct from conventional sedative-hypnotics while addressing the long-standing requirement for non-habit-forming therapeutic alternatives._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report_x000D_

_x000D_

#What Are the Key Regional Markets in the Insomnia Therapeutics Industry?#_x000D_

North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24255&type=smp_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the insomnia therapeutics market, and how is it changing globally?_x000D_

2. Who are the major companies in the insomnia therapeutics market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the insomnia therapeutics market right now?_x000D_

4. Which products or customer segments are growing the most in the insomnia therapeutics market?_x000D_

5. What factors are helping or slowing down the growth of the insomnia therapeutics market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model